Separation,Identification, and Quantification of N-Acetyl Cilastatin in Human Urine

Abstract

A new high-performance liquid chromatographic method coupled with anion-exchange sample extraction has been developed for the isolation and quantification of N-acetyl cilastatin from human urine samples. N-Acetyl cilastatin, isolated from urine after I.V. administration of cilastatin, was converted to dimethyl esters, and characterized by thin-layer chromatography and mass spectrometry. The detection limit of the assay was 5 μg/ml in urine. The method was shown to be linear, reproducible and reliable for the quantification of N-acetyl cilastatin in urine from four human subjects given I.V. doses of cilastatin alone and together with 250 and 1,000 mg of imipenem.     

Improved High Performance Liquid Chromatographic Method for the Quantification of 3-Methylhistidine in Serum and Urine

Abstract

We optimized an high-performance liquid chromatographic (HPLC) method for the determination of 3-methylhistidine (3-MeHis) in biological fluids. After pre-column derivatization with OPA, analytical separation was achieved on a reversed-phase C18 column by a simple gradient between sodium propionate buffer and acetonitrile. the method is accurate, reproducible and sensitive, and allows the determination of urinary 3-MeHis levels in about 55 min. Other additional 16 amino acids may be easily quantified while the 3-MeHis peak is well resolved from an unknown urinary compound potentially interfering.     

Determination of Salmeterol in Equine Urine and Serum

Salmeterol is a β₂-adrenergic agonist and an Association of Racing Commissioners International (ARCI) class 3 drug. Trade names of its xinafoate salt are Arial (Dompé), Salmetedur (Menarini), and Serevent (Glaxo). Salmeterol is routinely used to increase ease of breathing in race horses during their training. Due to its bronchodilating and central nervous system stimulant properties, its administration to a horse just prior to race time has the potential to affect the horse’s performance, therefore a reliable method of analysis for this compound is necessary. This paper describes a method for the identification and quantitation of salmeterol in equine urine using liquid-liquid extraction followed by liquid chromatography and tandem mass spectrometry (LC-MS-MS). Urine salmeterol concentrations peaked at about 2 h post-dose following administration of 500 ug both intravenously and intratracheally at concentrations of 14 ng mL^?1 and 4 ng mL^?1, respectively. Serum concentrations at 30 min were below the minimum level of quantitation.     

Simple, Sensitive, and Rapid LC–ESI-MS Method for Quantification of Mitiglinide in Human Urine

A sensitive and specific liquid chromatographic method with electrospray ionization mass spectrometry (LC–ESI-MS) has been developed and validated for identification and quantification of mitiglinide in human urine. A simple liquid–liquid extraction procedure was followed by separation on a C₁₈ column with gradient elution, and detection using a single-quadrupole mass spectrometer in selected-ion-monitoring (SIM) mode. The method was tested using six different batches of urine. Linearity was established for the mitiglinide concentrations in the range 0.005–1.0 μg mL⁻¹, with a coefficient of determination (r) of 0.9998 and good back-calculated accuracy and precision. Intra- and inter-day precision (as RSD, %) was below 10% and accuracy for mitiglinide ranged from 85 to 115%. The lower limit of quantification was reproducible at 0.002 μg mL⁻¹ for 500 μL urine. The proposed method enables unambiguous identification and quantification of mitiglinide in pre-clinical and clinical studies.     

毛细管电泳分离与测定尿液中扑尔敏对映体

以ＨＰ－β－ＣＤ作为手性分离添加剂,对标样和实际尿液中的扑尔敏进行了手性分离和测定研究。在实际样品的分离测定时,用液液萃取时间样品预处理,并采用电堆集进样以提高检测灵敏度,对于尿液中扑尔敏对映体的检测限为１．５×１０＾－７ｇ／Ｌ。     

Determination of Piribedil in Human Serum, Urine and Pharmaceutical Dosage Form by LC-DAD

A rapid, selective and sensitive reversed-phase liquid chromatographic (LC) method was developed for the determination of piribedil in human serum, urine and pharmaceutical dosage form. LC analysis was carried out using reversed-phase isocratic elution with a C₁₈ column and a mobile phase of 0.01 M phosphate buffer-acetonitrile (50:50, v/v). The chromatograms showed good resolution and sensitivity with no interference of human serum and urine. Piribedil concentrations were determined using diode array detection at 240 nm. Sildenafil citrate was used as internal standard. The limit of quantification (LOQ) and limit of detection (LOD) concentrations were 107.2 and 321.6 pg mL^?1, 96.6 and 290.4 pg mL^?1, 161.7 and 53.9 pg mL^?1 for urine, serum and pharmaceutical dosage forms, respectively. The method was validated for its linearity, precision and accuracy and applied to the tablets, urine and human serum. In addition, the results were compared to those obtained from UV-spectrophotometry.     

Facile, scalable, regioselective synthesis of C3v C60H18 using organic polyamines

[chemical structure: see text]. Organic polyamines are efficient reagents for the regioselective hydrogenation of [60]fullerene. When [60]fullerene is heated in diethylenetriamine, a known C60H18 isomer with C3v symmetry is produced and isolated in good purity without the need for chromatographic separation. The reaction can be scaled upward to multigram levels without impacting yield or quality of product.     

High-Performance Liquid Chromatographic Determination of Ceftazidime in Serum,Urine, CSF,and Peritoneal Dialysis Fluid

Abstract

A rapid, sensitive and specific high performance liquid chromatographic method is described for the determination of ceftazidime in serum, urine, CSF and peritoneal dialysis fluid. The procedure employs reversed-phase chromatography, using hydrochlorothiazide as an internal standard. The assay only requires 100 μl of sample with direct injection of diluted urine, CSF, peritoneal dialysis fluid or protein precipitated serum. Stability studies indicate good drug recovery if urine and serum are stored under proper conditions. The method is specific for ceftazidime in the presence of amikacin, gentamicin, kanamycin, tobramycin, methicillin, penicillin G, ampicillin, chloramphenicol and caffeine. The method has been successfully employed in the assay of over 700 samples obtained during human clinical trials.     

Quantification of Clenbuterol in Human Plasma and Urine by Liquid Chromatography-Tandem Mass Spectrometry

The quantitative determination of clenbuterol in human plasma and urine is of particular interest for various fields such as clinical and forensic research and doping controls. A simple and rapid sample preparation procedure based on liquid-liquid extraction with subsequent re-extraction followed by liquid chromatography and electrospray ionization tandem mass spectrometry allowed the determination of clenbuterol in urine and plasma at detection and quantification limits of 0.1 ng mL⁻¹ and 0.2 ng mL⁻¹, respectively, with recoveries ranging from 85–96%. The fast and robust nature of the assay provides a rapid and cost-effective alternative to established procedures utilizing solid-phase extraction strategies.     

膀胱癌血清及尿液代谢组学研究

应用代谢组学研究方法,对与膀胱癌(Bladder cancer,BC)发病相关的生物标志物进行筛选,采用液相色谱-电喷雾质谱(LC-ESI/MS)联用技术对20名膀胱癌患者与24名正常人的血清和尿液进行研究.多变量统计分析结果表明,膀胱癌患者和正常人聚类明显,血清和尿液中分别发现13个潜在标志物.其中,(2E,6E,8E)-二十二碳三烯-1-醇、7-((1S,2S)-2-(庚胺)环己基)庚酸和(11E,14E,17E)-三烯-二十碳-1-醇首次在血清中发现,有潜力成为膀胱癌诊断标志物.液相色谱-质谱联用结合多变量分析的代谢组学研究技术在膀胱癌诊断中展现出巨大潜力.     

甲亢患者血清和尿液的核磁共振代谢组学研究

应用基于核磁共振(NMR)的代谢组学方法, 研究甲状腺功能亢进(简称甲亢)患者和健康人群的血清和尿液, 分析甲亢疾病的特征代谢物. 实验收集33个甲亢患者和17个健康志愿者的血清样品以及53个甲亢患者和58个健康志愿者的尿液样品, 采用多元统计分析方法研究甲亢组和对照组血清和尿液中的内源性代谢差异. 结果表明, 甲亢组血清中的胆碱、葡萄糖和三甲胺等物质的含量升高, 而VLDL, LDL和胆固醇等脂质以及乳酸、糖蛋白和丙氨酸等代谢物的含量下降; 甲亢组尿液中的葡萄糖、柠檬酸、牛磺酸以及肌氨酸等代谢物的含量升高, 而马尿酸、TMAO、甲酸和琥珀酸等代谢物的含量下降. 结果表明, 甲亢病不仅影响了糖类、脂类和蛋白质三大物质的代谢, 还对能量代谢、肝肠循环和肠道微生物等多个生理系统产生显著影响, 并且可能造成肝脏及肾脏等器官的损伤.     

An Improved Technique for Extraction,Identification, and Quantification of Leukotrienes

Abstract

An improved method for extraction, separation and quantification of leukotrienes is described. Critical steps include extraction in thoroughly cleaned Sep-Pak C₁₈ mini columns, elution with 90 percent methanol in water, addition of 0.25 percent Na₄EDTA to the solvent system of methanol/water 60/40, pH 7.4, injection of the samples in 1 ml of the same system after lowering the pH to 3.0 with glacial acetic acid and utilization of a Z-module containing a 5 μm C₁₈ reverse phase cartridge. Recovery of the leukotrienes was 94 pm 8% mean pm SD for LTC₄, 89 pm 5% for LTD₄, 89 pm 3% for LTB₄ and 84 pm 6% for LTE₄. We had no problems with precipitation of Na₄EDTA and occlusion of the HPLC fittings. The method is simple, reproducible and easily adaptable to any research laboratory.     

Bioluminescent Flow Sensors: L-Alanine Determination in Serum and Urine

Abstract

A continuous flow bioluminescent method for L-alanine analysis in serum and urine has been developed. Serum can be analyzed directly after simple filtration. Response is linear from 50 to 1500 pmoles in biological matrix. Alanine dehydrogenase is immobilized onto a nylon coil separated from the reactor coil containing bioluminescent enzymes. The stability of nylon immobilized enzymes is high (over three months) and more than 900 samples can be analyzed with few mg of enzymes. The results obtained with the bioluminescent sensor agree well with those obtained by ion exchange chromatography (amino acid analyzer).     

High Performance Liquid Chromatographic Analysis of Cepoperazone in Serum and Urine

Abstract

A high performance liquid chromatographic method was developed for the quantitative analysis of cefoperazone in serum and urine. Standard curves were linear over the range of concentrations 2–30 μg/ml and a good correlation was established between the amount of cefoperazone injected and peak height. The mean percentage analytical recovery of cefoperazone was 96.3% and the mean within day coefficient of variation in serum was 2.8%. Serum and urine components, as well as several beta-lactam antibiotics, did not interfere with the measurement of cefoperazone. This is a rapid, reproducible, and sensitive assay suitable for use in pharmacokinetic studies.     

Isolation and Identification of Amphetamines in Urine by Thin-Layer Chromatography

JPC – Journal of Planar Chromatography – Modern TLC -     

阳虚体质者血清和尿液的核磁共振代谢组学

采用基于核磁共振(NMR)的代谢组学方法研究了中医阳虚体质及平和体质(正常对照)的血清和尿液, 分析了阳虚体质的特征代谢物. 实验收集阳虚体质及平和体质各30人的血清及尿液样品, 采用多元统计分析方法研究了阳虚质组和对照组血清和尿液中的内源性代谢差异. 结果表明, 阳虚质血清中乳酸、 极低密度脂蛋白/低密度脂蛋白、N-乙酰糖蛋白、脂肪酸及不饱和脂肪酸的含量降低, 谷氨酰胺、葡萄糖、磷脂酰胆碱及高密度脂蛋白的含量增多; 尿液中肌酐的含量降低, 乳酸、二甲胺、柠檬酸及马尿酸的含量增多. 阳虚体质的潜在生物标志物的发现从代谢组学角度为个体差异提供了新的依据. 阳虚体质与平和体质存在能量代谢、脂代谢及糖代谢的差异以及相关脏腑功能的改变.     

Purification of polar compounds from Radix isatidis using conventional C18 column coupled with polar-copolymerized C18 column

Regarding hydrophilic interaction chromatography and normal phase liquid chromatography, RPLC is another choice used to separate polar compounds with the improvement of polar-modified C18 stationary phase. In this study, a method using conventional C18 column coupled with polar-copolymerized C18 column was successfully developed for the separation and purification of polar compounds from Radix isatidis, which is one of the most commonly used traditional Chinese medicines (TCMs). An XTerra MS C18 column was used to fractionate the extract of R. isatidis and a homemade polar-copolymerized C18 column was utilized for the final purification due to its good separation selectivity and high resolution for polar compounds. The established purification system demonstrated good orthogonality for the polar compounds. As a result, ten compounds were purified and three of them were identified as 3-methyl-5-vinyloxazolidin-2-one (compound A), 5-hydroxymethyl-2-furaldehyde (compound B) and 3-methylfuran-2-carboxylic acid (compound G) based on the MS, IR and extensive NMR data, respectively. It was demonstrated to be a feasible and powerful technique for the purification of polar compounds under RPLC mode and more chemical information of TCMs will be obtained to interpret the efficiency of TCMs.